{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T00:29:24Z","timestamp":1778286564742,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2001,12,29]],"date-time":"2001-12-29T00:00:00Z","timestamp":1009584000000},"content-version":"vor","delay-in-days":89,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapeutic Apheresis"],"published-print":{"date-parts":[[2001,10]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Neutrophils are critical effector cells in humoral and innate immunity and play a vital role in phagocytosis and bacterial killing. If they and\/or their specific functions are lacking, then immunoparalysis may occur, and severe diseases like systemic inflammatory response syndrome (SIRS) or sepsis can take a fatal course. In this paper, we discuss the possibility of using preconditioned cells in an extracorporeal biohybrid immune support system. A human promyelocytic cell line was stimulated for different times with all\u2010trans retinoic acid. The resulting cells displayed major signs and functions of mature neutrophilic granulocytes including oxygen radical production, phagocytosis of living and dead <jats:italic>Escherichia coli, Staphylococcus aureus, Candida albicans,<\/jats:italic> intracellular killing, and interleukin production. The cells can be expanded to yield a sufficient cell mass, and subsequent prestimulation results in an expression of specific neutrophil functions. Extracorporeal bioreactor experiments seem to be feasible to test the benefit in immunoparalysis\u2010associated diseases like SIRS or sepsis.<\/jats:p>","DOI":"10.1046\/j.1526-0968.2001.00378.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:00:58Z","timestamp":1047502858000},"page":"423-432","source":"Crossref","is-referenced-by-count":16,"title":["Use of Human Preconditioned Phagocytes for Extracorporeal Immune Support: Introduction of a Concept"],"prefix":"10.1111","volume":"5","author":[{"given":"Steffen R.","family":"Mitzner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Freytag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilo","family":"Kleinfeldt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Kl\u00f6hr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Koball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Stange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Ringel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Nebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidrun","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Podbielski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Noeldge\u2010Schomburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,29]]},"reference":[{"key":"e_1_2_8_2_2","first-page":"317","volume-title":"Basic and clinical immunology","author":"Stites DP","year":"1991"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1385\/IR:21:2-3:49"},{"key":"e_1_2_8_4_2","doi-asserted-by":"publisher","DOI":"10.1006\/clim.2001.5007"},{"key":"e_1_2_8_5_2","first-page":"86","article-title":"Defective mononuclear phagocyte function in systemic lupus erythematosus: relationship of FcRII (CD32) with intermediate cytoskeletal filaments.","volume":"3","author":"Vazquez\u2010Doval J","year":"1993","journal-title":"J Investig Allergol Clin Immunol"},{"key":"e_1_2_8_6_2","first-page":"285","article-title":"Mononuclear phagocytic system in acute pancreatitis.","volume":"26","author":"Abdo EE","year":"1993","journal-title":"Braz J Med Biol Res"},{"key":"e_1_2_8_7_2","first-page":"87","article-title":"Defective function of the mononuclear phagocytic system in rats with chronic nephritis. Evidence of a decreased degradation of IgG aggregates by Kupffer cells.","volume":"63","author":"Herrero\u2010Beaumont G","year":"1988","journal-title":"Immunology"},{"key":"e_1_2_8_8_2","first-page":"481","article-title":"Role of phagocytic cells in cancer.","volume":"108","author":"Cron J","year":"1981","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70076-3"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-678"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-59467-0_7"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9610(91)91247-G"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199305000-00008"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5520(05)70075-1"},{"key":"e_1_2_8_15_2","first-page":"433","article-title":"Does treatment with haematopoietic growth factors affect the incidence of bacteraemia in adult lymphoma transplant recipients?","volume":"11","author":"Tsakona CP","year":"1993","journal-title":"Bone Marrow Transplant"},{"key":"e_1_2_8_16_2","first-page":"90","article-title":"Recombinant granulocyte colony\u2010stimulating factor (G\u2010CSF) in infectious diseases: still a debate.","volume":"113","author":"Wiedermann FJ","year":"2001","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2001.005002115.x"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1155\/1995\/90362"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1996.tb00630.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1681\/ASN.V104846","article-title":"Cytokine removal during continuous hemofiltration in septic patients.","volume":"10","author":"De Vriese AS","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199804000-00024"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2000.004002142.x"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2001.005002123.x"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199910000-00003"},{"key":"e_1_2_8_25_2","first-page":"97","article-title":"Modular extracorporeal liver support (MELS) bei Leberversagen.","volume":"8","author":"Kardassis D","year":"2001","journal-title":"J An\u00e4sth Intensivbehandlung"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510240625"},{"key":"e_1_2_8_27_2","first-page":"229","article-title":"A new approach to develop a biohybrid artificial liver using a tightly regulated human hepatocyte cell line.","volume":"13","author":"Kobayashi N","year":"2000","journal-title":"Hum Cell"},{"key":"e_1_2_8_28_2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1182\/blood.V54.3.713.713","article-title":"Characterization of the continuous, differentiating myeloid cell line (HL\u201060) from a patient with acute promyelocytic leukemia.","volume":"54","author":"Gallagher R","year":"1979","journal-title":"Blood"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0045-6039(87)90481-7"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005340170045"}],"container-title":["Therapeutic Apheresis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1526-0968.2001.00378.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1526-0968.2001.00378.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T05:56:33Z","timestamp":1697522193000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1526-0968.2001.00378.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,10]]}},"alternative-id":["10.1046\/j.1526-0968.2001.00378.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1526-0968.2001.00378.x","archive":["Portico"],"relation":{},"ISSN":["1091-6660","1526-0968"],"issn-type":[{"value":"1091-6660","type":"print"},{"value":"1526-0968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,10]]}}}